Literature DB >> 18588978

Pre-assembled tau filaments phosphorylated by GSK-3b form large tangle-like structures.

Carolyn A Rankin1, Qian Sun, T Chris Gamblin.   

Abstract

Hyperphosphorylated tau protein is a major component of neurofibrillary tangles, a prominent intracellular hallmark of Alzheimer's disease. Both hyperphosphorylated tau and neurofibrillary tangles have been shown to correlate with dementia in Alzheimer's disease, but the relationship between hyperphosphorylation and tangle formation is not clear. Using a cell-free in vitro model system, in which tau polymerization is induced by arachidonic acid, we show that GSK-3beta phosphorylation of pre-assembled tau filaments makes those filaments prone to coalesce into large neurofibrillary tangle-like structures. Five phosphorylation sites, S199, T205, T231, S396 and S404, were identified in the phosphorylated filaments; many of the five are within epitopes recognized by Alzheimer's disease-associated antibodies. These tangle-like structures are optically visible and are similar to those formed by polymerization of GSK-3beta phosphorylated tau monomer and to those isolated from Alzheimer's disease tissue. We conclude that the phosphorylation of tau by GSK-3beta either prior to or following polymerization promotes polymer/polymer interactions that result in stable clusters of tau filaments.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18588978      PMCID: PMC2607042          DOI: 10.1016/j.nbd.2008.05.011

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  36 in total

1.  Inhibition of tau polymerization by its carboxy-terminal caspase cleavage fragment.

Authors:  R W Berry; A Abraha; S Lagalwar; N LaPointe; T C Gamblin; V L Cryns; L I Binder
Journal:  Biochemistry       Date:  2003-07-15       Impact factor: 3.162

2.  Ligand-dependent tau filament formation: implications for Alzheimer's disease progression.

Authors:  M E King; V Ahuja; L I Binder; J Kuret
Journal:  Biochemistry       Date:  1999-11-09       Impact factor: 3.162

3.  The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein.

Authors:  P J Lu; G Wulf; X Z Zhou; P Davies; K P Lu
Journal:  Nature       Date:  1999-06-24       Impact factor: 49.962

4.  The conformations of filamentous and soluble tau associated with Alzheimer paired helical filaments.

Authors:  Warren J Goux
Journal:  Biochemistry       Date:  2002-11-19       Impact factor: 3.162

5.  Pseudo-phosphorylation of tau at Ser202 and Thr205 affects tau filament formation.

Authors:  Carolyn A Rankin; Qian Sun; T Chris Gamblin
Journal:  Brain Res Mol Brain Res       Date:  2005-07-29

6.  Anionic micelles and vesicles induce tau fibrillization in vitro.

Authors:  Carmen N Chirita; Mihaela Necula; Jeff Kuret
Journal:  J Biol Chem       Date:  2003-05-01       Impact factor: 5.157

7.  CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival.

Authors:  Hideki Shimura; Daniel Schwartz; Steven P Gygi; Kenneth S Kosik
Journal:  J Biol Chem       Date:  2003-11-10       Impact factor: 5.157

8.  A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads.

Authors:  E Braak; H Braak; E M Mandelkow
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

9.  The switch of tau protein to an Alzheimer-like state includes the phosphorylation of two serine-proline motifs upstream of the microtubule binding region.

Authors:  J Biernat; E M Mandelkow; C Schröter; B Lichtenberg-Kraag; B Steiner; B Berling; H Meyer; M Mercken; A Vandermeeren; M Goedert; E Mandelkow
Journal:  EMBO J       Date:  1992-04       Impact factor: 11.598

10.  C-terminal inhibition of tau assembly in vitro and in Alzheimer's disease.

Authors:  A Abraha; N Ghoshal; T C Gamblin; V Cryns; R W Berry; J Kuret; L I Binder
Journal:  J Cell Sci       Date:  2000-11       Impact factor: 5.285

View more
  11 in total

1.  Pseudohyperphosphorylation has differential effects on polymerization and function of tau isoforms.

Authors:  Benjamin Combs; Kellen Voss; T Chris Gamblin
Journal:  Biochemistry       Date:  2011-10-17       Impact factor: 3.162

2.  MiR-126 Regulates Growth Factor Activities and Vulnerability to Toxic Insult in Neurons.

Authors:  Woori Kim; Haneul Noh; Yenarae Lee; Jeha Jeon; Arthi Shanmugavadivu; Donna L McPhie; Kwang-Soo Kim; Bruce M Cohen; Hyemyung Seo; Kai C Sonntag
Journal:  Mol Neurobiol       Date:  2014-11-19       Impact factor: 5.590

3.  In vitro aggregation assays using hyperphosphorylated tau protein.

Authors:  Dexin Sui; Mengyu Liu; Min-Hao Kuo
Journal:  J Vis Exp       Date:  2015-01-02       Impact factor: 1.355

4.  High-Fructose Consumption Impairs the Redox System and Protein Quality Control in the Brain of Syrian Hamsters: Therapeutic Effects of Melatonin.

Authors:  Juan Carlos Bermejo-Millo; Marcela Rodrigues Moreira Guimarães; Beatriz de Luxán-Delgado; Yaiza Potes; Zulema Pérez-Martínez; Andrea Díaz-Luis; Beatriz Caballero; Juan José Solano; Ignacio Vega-Naredo; Ana Coto-Montes
Journal:  Mol Neurobiol       Date:  2018-02-28       Impact factor: 5.590

5.  Hsp70 alters tau function and aggregation in an isoform specific manner.

Authors:  Kellen Voss; Benjamin Combs; Kristina R Patterson; Lester I Binder; T Chris Gamblin
Journal:  Biochemistry       Date:  2012-01-23       Impact factor: 3.162

6.  Pseudohyperphosphorylation causing AD-like changes in tau has significant effects on its polymerization.

Authors:  Qian Sun; T Chris Gamblin
Journal:  Biochemistry       Date:  2009-06-30       Impact factor: 3.162

7.  Protein tau: prime cause of synaptic and neuronal degeneration in Alzheimer's disease.

Authors:  Natalia Crespo-Biel; Clara Theunis; Fred Van Leuven
Journal:  Int J Alzheimers Dis       Date:  2012-06-08

Review 8.  Protein phosphorylation in neurodegeneration: friend or foe?

Authors:  Sandra Tenreiro; Katrin Eckermann; Tiago F Outeiro
Journal:  Front Mol Neurosci       Date:  2014-05-13       Impact factor: 5.639

9.  Are tau aggregates toxic or protective in tauopathies?

Authors:  Catherine M Cowan; Amrit Mudher
Journal:  Front Neurol       Date:  2013-08-13       Impact factor: 4.003

10.  GSK-3beta phosphorylation of functionally distinct tau isoforms has differential, but mild effects.

Authors:  Kellen Voss; T Chris Gamblin
Journal:  Mol Neurodegener       Date:  2009-05-02       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.